Biomarkers in the diagnosis of Alzheimer's disease: are we ready? - Test2 - elhamkhani - TriplyDB

Biomarkers in the diagnosis of Alzheimer's disease: are we ready?

Biomarkers in the diagnosis of Alzheimer's disease: are we ready?

http://www.wikidata.org/entity/Q31050728

about

Prediction of cognitive decline in healthy older adults using fMRI Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.Network functional connectivity and whole-brain functional connectomics to investigate cognitive decline in neurodegenerative conditions Elman neural network for the early identification of cognitive impairment in Alzheimer's disease.Non-monotonic reorganization of brain networks with Alzheimer's disease progression.Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition.Off-label prescription of quetiapine in psychiatric disorders.Biomarkers in schizophrenia: a brief conceptual consideration.Dementia of the Alzheimer type.Semantic memory activation in amnestic mild cognitive impairment.Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.The epidemiology of delirium: challenges and opportunities for population studies.Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.Current concepts in Alzheimer's disease: a multidisciplinary review.The concept of FDG-PET endophenotype in Alzheimer's disease.Brain functional network in Alzheimer's disease: diagnostic markers for diagnosis and monitoring.Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy.Biomarkers for the identification and treatment of dementia.Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease.Diffusion tensor imaging for Alzheimer's disease: A review of concepts and potential clinical applicability.Electroencephalogram global field synchronization analysis: a new method for assessing the progress of cognitive decline in Alzheimer's disease.

P2860

Q28383378-9F3EFBEE-14FF-4336-99B5-DB58E3BD522C Q31111440-B7B1598A-7CA4-4B61-B558-6544505C5790 Q31153907-307FD172-D3DE-4627-A407-0FA49C48FE9B Q34230655-3A3986B4-BBE6-46CB-ACA9-B204BBF1263C Q35698877-836A8A7D-B460-4C1A-8BBD-9AF58014BFFA Q35846251-DE4181C8-1EC1-4FD7-BEB0-ECFE1E00CDA0 Q36725676-D7CE9728-E706-4354-9066-90EA2004F82E Q36870068-EC3916EF-DAC3-446E-9150-5C51DAC64F6F Q37176633-84C6F238-6C79-4DD9-BC22-50E9BE3E1EAB Q37219298-30D603CE-9A74-4F30-8F3A-D953A24E6A1B Q37270625-A87861E7-D96F-48E2-A8A6-6C8E8D200B67 Q37273675-211D67FE-A27F-42C6-83FC-1291CEE50529 Q37334341-D21C0193-4201-479E-8B44-826FC7443FF6 Q37358672-B12A9919-0D68-4565-93DF-26AADFDAB039 Q37360292-345167FD-D4CA-47AE-BD03-7EE250A74426 Q37883153-467D26E7-E0A8-4982-8FC3-1D5CB277A4CE Q42124171-C746B62F-AB3E-41D9-8FCF-E16D131A0575 Q42126269-DC403F83-0DAD-4FF8-9F22-CA42D226772B Q43064418-6BBD0FEF-BDEF-4E9E-B7F1-96BA58735BAE Q45344473-E98D7593-8767-43DD-B339-2A74126D52B8 Q46089160-3812D8F0-003E-4C56-8FF9-051BD19CC2DC Q51169150-8879154F-315C-422D-97B0-9D4D19BA096A

P2860

Biomarkers in the diagnosis of Alzheimer's disease: are we ready?

http://www.wikidata.org/entity/Q31050728

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Biomarkers in the diagnosis of Alzheimer's disease: are we ready?

@ast

Biomarkers in the diagnosis of Alzheimer's disease: are we ready?

@en

type

label

Biomarkers in the diagnosis of Alzheimer's disease: are we ready?

@ast

Biomarkers in the diagnosis of Alzheimer's disease: are we ready?

@en

prefLabel

Biomarkers in the diagnosis of Alzheimer's disease: are we ready?

@ast

Biomarkers in the diagnosis of Alzheimer's disease: are we ready?

@en

P1433

Q31050728-25440057-2F1E-4DB0-AB2A-0725A26A07D8

P1476

Q31050728-FDB7CEE6-5CA7-4AD3-8760-215E7C8E1070

P2093

Q31050728-1A099700-FFD5-4DF4-BE13-D26D19014994

Q31050728-1E864EEC-6215-4C1D-BC09-482107F32EB2

Q31050728-296E2D51-8FA5-424D-9DA2-9E0D4B071646

Q31050728-429443EC-6761-4152-A0F8-AC409F61B90C

P2860

Q31050728-0258FA0D-FE35-4098-A98D-87868D23D6D1

Q31050728-02838C9D-8853-46A5-A50B-0D0344E06962

Q31050728-0B31072E-F764-4F20-871B-07EE44A57405

Q31050728-0F7D5276-CC34-4577-9345-38EC2D611415

Q31050728-13E590CD-547A-43E3-B70E-45A5D71DE674

Q31050728-172E2E5D-5CEF-4B2A-ADC8-A757CA5A252E

Q31050728-1910B186-5130-47E6-937F-EE236CA970C2

Q31050728-1C2875F5-1C1C-41A9-AAB7-4C009FE5841E

Q31050728-1CE54E0C-C3B7-47F6-AFDD-D86286B39735

Q31050728-1EBBD1C3-F990-4FEA-9E8F-22EB6B8DE486

P304

Q31050728-4D921ABD-C000-4699-9E36-C2F469826307

P31

Q31050728-D0866F1E-F834-41BD-8E85-7301952E3417

P356

Q31050728-E82A3C4D-BA34-45A2-8229-E2919846F0A4

P433

Q31050728-A9A3E584-C73D-49EE-80C0-48A2BC9D71AD

P478

Q31050728-CF20FE8D-723E-4DF0-9A59-9EC3458048B1

P50

Q31050728-A46D8E68-4EFF-4BDC-A2EC-D54BA721F531

P577

Q31050728-D825F441-984D-46EC-BD45-41777829ECDA

P698

Q31050728-B0B9518F-00DC-46C1-9917-EF8E13E5ADA7

P921

Q31050728-3B980149-C4D1-4552-AD22-920809C7F116

Q31050728-68303BA7-E184-4B4F-B914-43E350AA254C

P356

0891988706291088

P1433

Journal of Geriatric Psychiatry and Neurology

P1476

Biomarkers in the diagnosis of Alzheimer's disease: are we ready?

@en

P2093

Karen T Putnam

http://www.w3.org/2001/XMLSchema#string

Masatoshi Takeda

http://www.w3.org/2001/XMLSchema#string

Robert M Cohen

http://www.w3.org/2001/XMLSchema#string

Trey Sunderland

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Mild cognitive impairment: clinical characterization and outcome

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

The Alzheimer's disease neuroimaging initiative.

Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment.

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease.

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.

P304

172-179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0891988706291088

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16880359

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease